生存率-话题@MedSci

#生存率#

482篇内容 | 6671人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256672, encodeId=d37812566e232, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Heart：作为移植过渡的左心室辅助装置患者的生存率及治疗预后, objectType=article, longId=147178, objectId=8d5714e17892, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d5714e17892, replyNumber=0, likeNumber=101, createdTime=2018-08-23, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d5714e17892, moduleTitle=Heart：作为移植过渡的左心室辅助装置患者的生存率及治疗预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d5714e17892)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256671, encodeId=d91512566e11d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet：1型糖尿病：发病年龄影响生存率和心血管结局？, objectType=article, longId=146532, objectId=52ec1465321e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52ec1465321e, replyNumber=0, likeNumber=72, createdTime=2018-08-14, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52ec1465321e, moduleTitle=Lancet：1型糖尿病：发病年龄影响生存率和心血管结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52ec1465321e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256670, encodeId=bb9e12566e08a, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Rheumatol：系统性硬化症—系统性红斑狼疮重叠综合征的流行病学和生存率, objectType=article, longId=146423, objectId=5f881464231d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f881464231d, replyNumber=0, likeNumber=116, createdTime=2018-08-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f881464231d, moduleTitle=J Rheumatol：系统性硬化症—系统性红斑狼疮重叠综合征的流行病学和生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f881464231d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256669, encodeId=50b4125666956, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Hepatol：FOLFOX肝动脉灌注可改善晚期肝细胞癌生存率？, objectType=article, longId=146110, objectId=147214611030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=147214611030, replyNumber=0, likeNumber=79, createdTime=2018-08-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=147214611030, moduleTitle=J Hepatol：FOLFOX肝动脉灌注可改善晚期肝细胞癌生存率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=147214611030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256668, encodeId=5c1d12566689c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=CCLM：结直肠腺癌中microRNA-28-5p高表达可预测淋巴结阴性患者的短期复发和非转移性疾病患者较低的总体生存率, objectType=article, longId=145555, objectId=1638145555dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1638145555dc, replyNumber=0, likeNumber=89, createdTime=2018-08-02, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1638145555dc, moduleTitle=CCLM：结直肠腺癌中microRNA-28-5p高表达可预测淋巴结阴性患者的短期复发和非转移性疾病患者较低的总体生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1638145555dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256667, encodeId=fc12125666e9c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Hepatol：直接抗病毒药物提高了肝移植后患者的早期生存率，并引起肝移植等待名单的显著变化, objectType=article, longId=145195, objectId=f7b21451958d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7b21451958d, replyNumber=0, likeNumber=86, createdTime=2018-07-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7b21451958d, moduleTitle=J Hepatol：直接抗病毒药物提高了肝移植后患者的早期生存率，并引起肝移植等待名单的显著变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7b21451958d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256666, encodeId=133f1256666a4, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAHA：冠状动脉旁路移植术患者的虚弱与长期生存率的关系, objectType=article, longId=144884, objectId=0a6714488456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a6714488456, replyNumber=0, likeNumber=106, createdTime=2018-07-22, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a6714488456, moduleTitle=JAHA：冠状动脉旁路移植术患者的虚弱与长期生存率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a6714488456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256665, encodeId=301b125666561, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Natl Cancer Inst：诺模图能预测晚期结直肠癌的生存率？, objectType=article, longId=144329, objectId=fcb514432948, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcb514432948, replyNumber=0, likeNumber=84, createdTime=2018-07-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcb514432948, moduleTitle=J Natl Cancer Inst：诺模图能预测晚期结直肠癌的生存率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcb514432948)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256664, encodeId=65151256664f4, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Hepatol：长期恩替卡韦/替诺福韦治疗CHB 生存率影响几何？, objectType=article, longId=141768, objectId=a500141e68d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a500141e68d7, replyNumber=0, likeNumber=102, createdTime=2018-06-29, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a500141e68d7, moduleTitle=J Hepatol：长期恩替卡韦/替诺福韦治疗CHB 生存率影响几何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a500141e68d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256663, encodeId=2e9d12566632e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Rheumatol：脊柱关节炎患者10年TNFi药物生存率的比较分析及预测因素, objectType=article, longId=141443, objectId=c0ee14144387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0ee14144387, replyNumber=0, likeNumber=82, createdTime=2018-06-25, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0ee14144387, moduleTitle=J Rheumatol：脊柱关节炎患者10年TNFi药物生存率的比较分析及预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0ee14144387)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256662, encodeId=c4fa125666218, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Circ: Cardiovascular Interventions：手术高危二尖瓣返流患者二尖瓣夹合术后的生存率, objectType=article, longId=140933, objectId=a50d140933ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a50d140933ae, replyNumber=0, likeNumber=117, createdTime=2018-06-18, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a50d140933ae, moduleTitle=Circ: Cardiovascular Interventions：手术高危二尖瓣返流患者二尖瓣夹合术后的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a50d140933ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256661, encodeId=7d80125666187, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=赫捷院士：中国恶性肿瘤5年生存率已提升至40.5%, objectType=article, longId=140453, objectId=26c014045397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26c014045397, replyNumber=0, likeNumber=74, createdTime=2018-06-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26c014045397, moduleTitle=赫捷院士：中国恶性肿瘤5年生存率已提升至40.5%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26c014045397)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256660, encodeId=95a11256660b1, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Aliment Pharmacol Ther：抗病毒治疗可提高乙肝病毒相关肝细胞癌患者的生存率, objectType=article, longId=140424, objectId=6c87140424b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c87140424b8, replyNumber=0, likeNumber=99, createdTime=2018-06-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c87140424b8, moduleTitle=Aliment Pharmacol Ther：抗病毒治疗可提高乙肝病毒相关肝细胞癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c87140424b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256659, encodeId=ecf11256659f5, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet：人白蛋白治疗可提高失代偿性肝硬化患者的生存率, objectType=article, longId=139713, objectId=53d8139e13a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53d8139e13a9, replyNumber=0, likeNumber=97, createdTime=2018-06-03, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53d8139e13a9, moduleTitle=Lancet：人白蛋白治疗可提高失代偿性肝硬化患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53d8139e13a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256658, encodeId=07831256658fe, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Journal of Clinical Gastroenterology：溃疡性结肠炎患者结肠巨细胞病毒感染的抗病毒治疗显着提高了其手术无生存率, objectType=article, longId=139692, objectId=7abe13969219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7abe13969219, replyNumber=0, likeNumber=112, createdTime=2018-06-03, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7abe13969219, moduleTitle=Journal of Clinical Gastroenterology：溃疡性结肠炎患者结肠巨细胞病毒感染的抗病毒治疗显着提高了其手术无生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7abe13969219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256657, encodeId=4ab5125665e93, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=未来科学大奖得主卢煜明:利用DNA检测提高病人生存率, objectType=article, longId=139500, objectId=5097139500d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5097139500d1, replyNumber=0, likeNumber=95, createdTime=2018-06-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5097139500d1, moduleTitle=未来科学大奖得主卢煜明:利用DNA检测提高病人生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5097139500d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256656, encodeId=94e11256656ca, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Ann Rheum Dis：肉芽肿病伴多血管炎引起的终末期肾病患者肾移植后的生存率改善, objectType=article, longId=138223, objectId=bc4a138223ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc4a138223ec, replyNumber=0, likeNumber=104, createdTime=2018-05-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc4a138223ec, moduleTitle=Ann Rheum Dis：肉芽肿病伴多血管炎引起的终末期肾病患者肾移植后的生存率改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc4a138223ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256655, encodeId=ac0e125665595, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Liver Int：与病毒性HCC患者相比，隐型肝癌患者的肿瘤更大，肿瘤分期愈晚，总体生存率较低, objectType=article, longId=138154, objectId=208313815466, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=208313815466, replyNumber=0, likeNumber=88, createdTime=2018-05-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=208313815466, moduleTitle=Liver Int：与病毒性HCC患者相比，隐型肝癌患者的肿瘤更大，肿瘤分期愈晚，总体生存率较低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=208313815466)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256654, encodeId=7e53125665480, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=PLos One：S100A16异常表达可作为非小细胞肺腺癌不良生存率的独立预后指标, objectType=article, longId=138049, objectId=e64e13804901, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e64e13804901, replyNumber=0, likeNumber=21, createdTime=2018-05-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e64e13804901, moduleTitle=PLos One：S100A16异常表达可作为非小细胞肺腺癌不良生存率的独立预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e64e13804901)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256653, encodeId=01d81256653f7, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Oncol：改善癌症患者生存率健康保险功不可没, objectType=article, longId=137820, objectId=413b13e82037, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=413b13e82037, replyNumber=0, likeNumber=60, createdTime=2018-05-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=413b13e82037, moduleTitle=JAMA Oncol：改善癌症患者生存率健康保险功不可没, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=413b13e82037)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Heart：作为移植过渡的左心室辅助装置患者的生存率及治疗预后

2018-08-23

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet：1型糖尿病：发病年龄影响生存率和心血管结局？

2018-08-14

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Rheumatol：系统性硬化症—系统性红斑狼疮重叠综合征的流行病学和生存率

2018-08-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Hepatol：FOLFOX肝动脉灌注可改善晚期肝细胞癌生存率？

2018-08-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

CCLM：结直肠腺癌中microRNA-28-5p高表达可预测淋巴结阴性患者的短期复发和非转移性疾病患者较低的总体生存率

2018-08-02

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Hepatol：直接抗病毒药物提高了肝移植后患者的早期生存率，并引起肝移植等待名单的显著变化

2018-07-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAHA：冠状动脉旁路移植术患者的虚弱与长期生存率的关系

2018-07-22

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Natl Cancer Inst：诺模图能预测晚期结直肠癌的生存率？

2018-07-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Hepatol：长期恩替卡韦/替诺福韦治疗CHB 生存率影响几何？

2018-06-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Rheumatol：脊柱关节炎患者10年TNFi药物生存率的比较分析及预测因素

2018-06-25

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Circ: Cardiovascular Interventions：手术高危二尖瓣返流患者二尖瓣夹合术后的生存率

2018-06-18

guoyibin (审核中...)

前往app查看评论内容

#生存率#

赫捷院士：中国恶性肿瘤5年生存率已提升至40.5%

2018-06-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Aliment Pharmacol Ther：抗病毒治疗可提高乙肝病毒相关肝细胞癌患者的生存率

2018-06-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet：人白蛋白治疗可提高失代偿性肝硬化患者的生存率

2018-06-03

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Journal of Clinical Gastroenterology：溃疡性结肠炎患者结肠巨细胞病毒感染的抗病毒治疗显着提高了其手术无生存率

2018-06-03

guoyibin (审核中...)

前往app查看评论内容

#生存率#

未来科学大奖得主卢煜明:利用DNA检测提高病人生存率

2018-06-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Ann Rheum Dis：肉芽肿病伴多血管炎引起的终末期肾病患者肾移植后的生存率改善

2018-05-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Liver Int：与病毒性HCC患者相比，隐型肝癌患者的肿瘤更大，肿瘤分期愈晚，总体生存率较低

2018-05-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

PLos One：S100A16异常表达可作为非小细胞肺腺癌不良生存率的独立预后指标

2018-05-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Oncol：改善癌症患者生存率健康保险功不可没

2018-05-12

科室
- - 订阅+
  - 更多科室
工具
服务